BioCentury
ARTICLE | Clinical News

Singulair montelukast regulatory update

January 19, 2009 8:00 AM UTC

FDA said a preliminary analysis of data from clinical trials of Merck's Singulair montelukast and other leukotriene modifying drugs for asthma do not suggest the agents are associated with suicide or ...